Viewing Study NCT06610760



Ignite Creation Date: 2024-10-26 @ 3:41 PM
Last Modification Date: 2024-10-26 @ 3:41 PM
Study NCT ID: NCT06610760
Status: NOT_YET_RECRUITING
Last Update Posted: None
First Post: 2024-09-19

Brief Title: Efficacy and Safety of Ursodeoxycholic Acid in Reversing Gastric Intestinal Metaplasia
Sponsor: None
Organization: None

Study Overview

Official Title: Efficacy and Safety of Ursodeoxycholic Acid in Reversing Gastric Intestinal Metaplasia A Multicenter Randomized Placebo-Controlled Trial
Status: NOT_YET_RECRUITING
Status Verified Date: 2024-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The goal of this clinical trial is to investigate the efficacy of ursodeoxycholic acid in treating gastric intestinal metaplasia in Helicobacter pylori-negative adults It will also learn about the safety of ursodeoxycholic acid The main questions it aims to answer are

Does ursodeoxycholic acid promote the regression of IM in individuals without Helicobacter pylori infection What medical problems do participants experience when taking ursodeoxycholic acid Researchers will compare ursodeoxycholic acid to a placebo a look-alike substance that contains no drug to see if ursodeoxycholic acid is effective in treating gastric intestinal metaplasia

Participants will

Take ursodeoxycholic acid or a placebo every day for 6 months Visit the clinic once every 4 weeks for checkups and tests
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None